Lin, H.-T.; Cheng, M.-L.; Lo, C.-J.; Lin, G.; Lin, S.-F.; Yeh, J.-T.; Ho, H.-Y.; Lin, J.-R.; Liu, F.-C.
1H Nuclear Magnetic Resonance (NMR)-Based Cerebrospinal Fluid and Plasma Metabolomic Analysis in Type 2 Diabetic Patients and Risk Prediction for Diabetic Microangiopathy. J. Clin. Med. 2019, 8, 874.
https://doi.org/10.3390/jcm8060874
AMA Style
Lin H-T, Cheng M-L, Lo C-J, Lin G, Lin S-F, Yeh J-T, Ho H-Y, Lin J-R, Liu F-C.
1H Nuclear Magnetic Resonance (NMR)-Based Cerebrospinal Fluid and Plasma Metabolomic Analysis in Type 2 Diabetic Patients and Risk Prediction for Diabetic Microangiopathy. Journal of Clinical Medicine. 2019; 8(6):874.
https://doi.org/10.3390/jcm8060874
Chicago/Turabian Style
Lin, Huan-Tang, Mei-Ling Cheng, Chi-Jen Lo, Gigin Lin, Shu-Fu Lin, Jiun-Ting Yeh, Hung-Yao Ho, Jr-Rung Lin, and Fu-Chao Liu.
2019. "1H Nuclear Magnetic Resonance (NMR)-Based Cerebrospinal Fluid and Plasma Metabolomic Analysis in Type 2 Diabetic Patients and Risk Prediction for Diabetic Microangiopathy" Journal of Clinical Medicine 8, no. 6: 874.
https://doi.org/10.3390/jcm8060874
APA Style
Lin, H.-T., Cheng, M.-L., Lo, C.-J., Lin, G., Lin, S.-F., Yeh, J.-T., Ho, H.-Y., Lin, J.-R., & Liu, F.-C.
(2019). 1H Nuclear Magnetic Resonance (NMR)-Based Cerebrospinal Fluid and Plasma Metabolomic Analysis in Type 2 Diabetic Patients and Risk Prediction for Diabetic Microangiopathy. Journal of Clinical Medicine, 8(6), 874.
https://doi.org/10.3390/jcm8060874